Angiodynamics Inc. ANGO

What this company does

AngioDynamics, Inc. designs, manufactures and sells products and technologies which aid clinicians in the treatment of patients with cardiovascular disease and cancer diagnoses. Its product offerings fall within two segments, Med Tech and Med Device. Within its Med Tech segment, its Thrombus Management portfolio includes the AlphaVac Mechanical Thrombectomy System, the AngioVac venous drainage cannula and circuit, and catheter directed thrombolytic devices, including the Uni-Fuse system and the Uni-Fuse+ system. Within its Med Device segment, it offers products for use during minimally invasive procedures, with product categories including angiographic catheters, guidewires, drainage catheters and micropuncture kits. It sells its devices in the United States primarily through a direct sales force and internationally through a combination of direct sales and distributor relationships. As of May 31, 2026, the company had approximately 632 full-time employees. AngioDynamics was founded in Queensbury, N.Y., in 1988, and the company is headquartered in Latham, N.Y., with manufacturing primarily out of the Queensbury facility.

Written from the business description in AngioDynamics, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 14 July 2026. Every sentence was checked against that document before publication.